There's been a recent increase globally in outbreaks of vaccine-preventable diseases. This can be seen in recent measles outbreaks in parts of the world where it was thought to have been eradicated.
Feb 13, 2019
1
3
Discussion about cardiac arrest on Twitter is common and represents a new opportunity to provide lifesaving information to the public, according to new research from the Perelman School of Medicine at the University of Pennsylvania. ...
Nov 12, 2011
2
0
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations.
Apr 30, 2019
0
675
One of the greatest challenges in the field of neurology and intensive care medicine is correctly diagnosing the level of consciousness of a patient in coma due to severe brain injury. Scientists of the Human Brain Project ...
Sep 16, 2022
0
125
The bad news, not that anyone needs more of it: The dangers of COVID-19 could worsen if misinformation on social media continues to spread unchecked. Essentially, what people choose to share on social media about the pandemic ...
Jul 2, 2020
0
26
The largest ever survey on global public attitudes towards genomic research and data sharing suggests that work is needed to raise levels of public trust in how genetic data is used in order for that data to fulfil its promise ...
Sep 17, 2020
0
81
Girls and boys might be more vulnerable to the negative effects of social media use at different times during their adolescence, say an international team of scientists.
Mar 28, 2022
1
89
Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of dollars by selling shares in their companies—raising questions about the propriety of ...
Nov 15, 2020
0
14
The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat COVID-19, the company said Friday.
Oct 14, 2023
0
1
A blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage for lung cancer patients.
Aug 5, 2016
0
2
